Agence nationale de santé publique (France)

Agence nationale de santé publique (France) is the French national public health agency created to coordinate prevention, surveillance, preparedness and response for population health in metropolitan and overseas territories. It integrates functions formerly dispersed among multiple institutions to provide centralized expertise on communicable diseases, environmental health, occupational risks and health promotion. The agency operates within the French administrative and legal landscape and collaborates with European and international bodies to implement public health policy and emergency interventions.

History

The agency was formed in 2016 through consolidation of predecessors including Institut de veille sanitaire, Agence française de sécurité sanitaire de l'environnement et du travail, and parts of Haute Autorité de santé, reflecting reforms following public debates after crises such as the Mad Cow Disease controversy and the 2009 flu pandemic. Its creation was enacted under the administration of Manuel Valls and within the policy agenda of Marisol Touraine and Olivier Véran's successors, positioned alongside institutions like Assurance Maladie and Institut national de la santé et de la recherche médicale. The consolidation aimed to strengthen links with regional agencies such as Agence régionale de santé and international partners including European Centre for Disease Prevention and Control, World Health Organization, and Organisation for Economic Co-operation and Development. Major operational tests included responses to the 2016–2017 Zika virus epidemic and the COVID-19 pandemic in France, during which coordination with entities like Élysée Palace, Ministry of the Interior (France), and Conseil scientifique COVID-19 was prominent.

Legal framework and governance

The agency operates under statutes enacted by the French Parliament and is accountable to the Ministry of Solidarity and Health and oversight bodies such as the Cour des comptes for public expenditure. Its legal basis draws on legislation including health codes shaped by precedents like the Loi HPST (Hôpital, Patients, Santé et Territoires) and frameworks established after rulings by the Conseil d'État. Governance structures include a board composed of representatives from agencies such as Santé publique France, advisory committees with members from Académie nationale de médecine, and partnerships with research funders like Agence nationale de la recherche and Inserm. The director-general is appointed by decree of the Prime Minister with input from ministries including Ministry of Budget (France) and subject to public procurement rules under EU law as overseen by European Commission directives.

Organization and functions

The agency is organized into directorates covering infectious diseases, chronic diseases, environmental health, occupational health, and health promotion, working with laboratories such as the National Reference Centre (France) and university hospitals like Assistance Publique–Hôpitaux de Paris. Functional units include surveillance, risk assessment, communication, and regional coordination linked to entities like Agence régionale de santé Île-de-France. Core functions encompass epidemiological monitoring, vaccination strategy support in liaison with Direction générale de la santé, screening program oversight in partnership with Haute Autorité de santé, and incident management alongside Sécurité civile (France). Operational collaborations extend to research institutes including Centre national de la recherche scientifique, pharmaceutical regulators like Agence nationale de sécurité du médicament et des produits de santé, and international networks such as Global Outbreak Alert and Response Network.

Public health surveillance and response

Surveillance systems run by the agency integrate data streams from sentinel networks, hospital information systems including Système d'information de surveillance, laboratory reporting through Centre national de référence, and field reporting coordinated with regional partners like Agence régionale de santé Provence-Alpes-Côte d'Azur. The agency maintains epidemic intelligence capacities similar to those of European Centre for Disease Prevention and Control and operational response teams modeled on Field Epidemiology Training Program practices. In outbreak response, it coordinates contact tracing, testing logistics with providers such as Réseau Sentinelles, vaccination campaigns in collaboration with Assurance Maladie and pharmaceutical distributors, and risk communication drawing on crisis cells used during the 2015–2016 European migrant crisis and the COVID-19 pandemic. The agency also runs surveillance for environmental hazards—including air pollution monitored in partnership with Airparif and water quality assessed with Agence française pour la biodiversité—and occupational exposures in coordination with Inspection du travail.

Research, training and partnerships

Research activities are conducted with academic partners such as Université Paris-Saclay, Sorbonne Université, and Université de Strasbourg, and with national institutes including Inserm and CNRS to support evidence synthesis, modelling, and operational research. The agency hosts training programs and collaborates with educational institutions like École des Hautes Études en Santé Publique and École nationale supérieure de sécurité sociale to develop public health capacity, internships and fellowships tied to European Public Health Association exchanges. International partnerships span World Health Organization, European Commission, Centers for Disease Control and Prevention, and bilateral cooperation with ministries such as Ministry of Health and Social Protection (Brazil) and National Health Commission (China). The agency publishes scientific reports, surveillance bulletins and technical guidelines to inform policy-makers including Assemblée nationale committees and municipal authorities like Mairie de Paris.

Category:Public health in France